biomarker

How’s my driving? GPS tracking spots Alzheimer’s with 86% accuracy

https://pharmaphorum.com/news/hows-my-driving-gps-tracking-spots-alzheimers-with-86-accuracy/

physIQ licenses virtual trial tech to Janssen in multi-year deal

https://pharmaphorum.com/news/physiq-licenses-virtual-trial-tech-to-janssen-in-multi-year-deal/

Limited access to cancer biomarker testing in Europe, report finds

https://pharmaphorum.com/news/limited-access-to-biomarker-testing-in-europe-report-finds/

AI startup Nucleai has immuno-oncology treatment failures in its sights

https://pharmaphorum.com/news/ai-startup-nucleai-has-immuno-oncology-treatment-failures-in-its-sights/

Merck & Co’s Keytruda approved for second “tumour agnostic” use

https://pharmaphorum.com/news/merck-cos-keytruda-approved-for-second-tumour-agnostic-use/

4th Microbiome Movement – Drug Development Europe Summit

https://pharmaphorum.com/events/4th-microbiome-movement-drug-development-europe-summit/

Mike Page, Alexion Pharmaceuticals invite to SMi’s Orphan Drugs & Rare Diseases

https://pharmaphorum.com/partner-content/mike-page-alexion-pharmaceuticals-invite-to-smis-orphan-drugs-rare-diseases/

Global Biobanking Congress

https://pharmaphorum.com/events/global-biobanking-congress/

Cancer blood test firm Grail mulls IPO

https://pharmaphorum.com/news/cancer-blood-test-firm-grail-mulls-hong-kong-ipo/

1 2

Close in 10 seconds

Pharmaphorum.com

Search